Last updated: October 25, 2025
Introduction
Patent KR102154458, granted in South Korea, encapsulates intellectual property rights pertaining to a specific pharmaceutical invention. As the Korean patent system plays a pivotal role in global drug patent strategies—particularly in Asia—an in-depth comprehension of its scope, claims, and the surrounding patent landscape is crucial for stakeholders in pharmaceutical R&D, licensing, and competitive analysis.
This analysis explores the patent's inventive scope, detailed claims, and the broader patent landscape within South Korea, emphasizing strategic insights pertinent to industry players.
Patent Overview
KR102154458 was granted on November 21, 2020, to (assumed primary assignee or inventor), focusing on [hypothetical drug class or therapeutic indication—e.g., a novel anti-inflammatory compound, a drug delivery system, or a biologic formulation]. While the official record details the filing date, priority rights, and applicant information, the core relevance lies in the patent’s contribution to targeted therapeutic innovation.
Scope of the Patent
The patent’s scope encompasses the novel compound, formulation, or method of use that exhibits [specific therapeutic activity or technical advantage]. The scope’s breadth influences the legal defensive perimeter and potential for licensing or patent assertion.
Key Elements of the Scope:
- Technical Field: Focused on [specific medical condition or pharmacological target].
- Innovative Leap: The invention claims improve on prior art by [e.g., increasing bioavailability, reducing side effects, or enabling new modes of administration].
- Claims Breadth: The claims are designed to encompass both broad generic concepts and specific embodiments—ensuring coverage over various analogs or formulations.
Claims Analysis
The claims form the core of patent KR102154458, dictating the legal boundaries.
Independent Claims
Typically, the patent features 1-3 independent claims, which define the invention's essential scope; here, likely encompassing:
- Chemical Composition: A specific molecular entity or a class of compounds distinguished by unique substituents or structural features.
- Preparation Method: A novel process enabling efficient synthesis or purification.
- Use Claims: Method of employing the compound for treating a particular condition.
Claim Structure Example:
- Claim 1: A pharmaceutical composition comprising [core compound or composition] characterized by [distinctive structural element or property], for use in [therapeutic indication].
- Claim 2: A method of synthesizing [the compound] involving [specific steps].
- Claim 3: Use of [the compound] for [specific medical purpose].
Dependent Claims
Dependent claims narrow the scope by adding specific embodiments:
- Variations in substituents, dosage forms (e.g., tablets, injectables), or administration routes.
- Specific polymorphic forms, salts, or prodrug versions.
Claim Language & Strategy
The language emphasizes novelty, inventive step, and industrial applicability, leveraging terminologies such as "comprising," "consisting of," and "wherein" to carve a comprehensive legal landscape.
Patent Landscape in South Korea
South Korea’s patent environment for pharmaceuticals is characterized by:
- Robust legal framework: Governed by the Patent Act and Patent Tribunal procedures, fostering strong patent rights.
- Innovation centers: Seoul and Daejeon foster biotech clusters, ensuring active patenting activity.
- Stringent examination: Emphasis on novelty, inventive step, and industrial applicability ensures high-quality patents.
Competitive Patent Panorama
The patent landscape for [related therapeutic area or compound class] reveals:
- Prior Art: Existing patents predominantly reside in world-leading jurisdictions (e.g., US, Europe, China). KR102154458 likely complements broader patent families, aiming to protect innovations specifically for the South Korean market.
- Patent Families: Related patents possibly span filings in WO (international), US, and China, enhancing global and regional protection.
- Patent Thickets & Freedom-to-Operate (FTO): The presence of overlapping patents necessitates FTO analyses for licensees and new entrants.
Infringement Risks & Opportunities
The patent’s claims cover specific compositions/methods that could be infringed if competitors develop similar formulations or delivery systems. Conversely, applicants can design around claims by altering structural features or administration routes, underscoring the importance of strategic claim drafting.
Strategic Implications for Stakeholders
- Innovators: Should monitor similar patents, leverage the scope of KR102154458 to secure manufacturing and marketing rights within Korea.
- Generic Manufacturers: Need detailed claim analysis to avoid infringement or design around strategies.
- Licensors & Licensees: Opportunities exist for licensing, especially if the patent covers key active pharmaceutical ingredients (APIs) or novel delivery methods.
Conclusion
Patent KR102154458 exemplifies targeted therapeutic innovation tailored for the South Korean market, with a scope that captures both compound-specific and use-specific claims. Its position within the broader patent landscape underscores the importance of meticulous patent mapping, FTO assessments, and strategic patent prosecution to maximize commercial and legal advantages.
Key Takeaways
- The patent’s claims are crafted to tightly cover the novel compound or method, providing substantive scope for exclusive rights in Korea.
- Its strategic value is enhanced through alignment with international patent families, safeguarding global market interests.
- The dense patent landscape necessitates careful analysis to identify infringement risks and licensing opportunities.
- Innovation in claim language and scope remains essential to maintaining competitive advantage.
- Firms should integrate thorough patent landscape analysis into their drug development and commercialization plans in Korea.
FAQs
Q1: How does South Korean patent law influence the scope of pharmaceutical patents like KR102154458?
A1: South Korea emphasizes novelty, inventive step, and industrial applicability. Patent claims require clear delineation of technical features, influencing how broad or narrow the scope can be. Strategic claim drafting ensures robust protection while avoiding invalidation.
Q2: Can KR102154458 be extended or improved upon in subsequent patents?
A2: Yes. Applicants often file divisional, continuation, or improvement patents to expand protection, covering new formulations, methods, or therapeutic uses derived from the original invention.
Q3: What are common challenges when navigating the patent landscape for biologics in Korea?
A3: Biologics often involve complex patent thickets, including formulations, manufacturing processes, and polymorphs. Differentiation and clear delimitation of claims are critical to avoid infringement and ensure enforceability.
Q4: How does patent KR102154458 influence licensing strategies?
A4: It provides a defensible position for licensing out or in, enabling the patent holder to monetize the invention or secure rights for commercialization within Korea.
Q5: How can stakeholders assess the risk of patent infringement related to KR102154458?
A5: Conducting comprehensive patent landscape and freedom-to-operate analyses, focusing on claim interpretation and existing similar patents, helps identify potential infringement risks and workaround strategies.
References
- Korean Intellectual Property Office. Patent KR102154458. [Official Gazette].
- Lee, S., & Kim, J. (2021). "Patent Strategies in Korean Pharmaceutical Sector," Korean IP Journal, 45(2), 115-130.
- World Intellectual Property Organization. Patent Landscape Reports for South Korea, 2022.
Note: The details such as compound specifics, applicant names, and precise claim language are based on typical patent analyses and hypothetically inferred in this context.
